In Wake of Dispute with Ariadne, Stratagene Inks Bioinformatics Software Deal with Strand | GenomeWeb

Following a dispute with bioinformatics partner Ariadne, Stratagene said last week that it would collaborate with Strand Life Sciences to develop bioinformatics software to analyze biological pathways and Affymetrix's new GeneChip microarrays.

Terms of the agreement call for the companies to co-design and co-develop software based on Strand's Avadis technology. Stratagene will exclusively market and sell the two products "shortly," the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.